Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Revenue

Guilin Sanjin Pharmaceutical had revenue of 464.04M CNY in the quarter ending September 30, 2025, a decrease of -8.36%. This brings the company's revenue in the last twelve months to 2.08B, down -1.56% year-over-year. In the year 2024, Guilin Sanjin Pharmaceutical had annual revenue of 2.19B with 1.03% growth.

• Revenue (ttm): 2.08B
• Revenue Growth: -1.56%
• P/S Ratio: 3.94
• Revenue / Employee: 810.90K
• Employees: 2,567
• Market Cap: 8.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.19B	22.39M	1.03%
Dec 31, 2023	2.17B	211.87M	10.81%
Jan 1, 2023	1.96B	218.51M	12.55%
Jan 1, 2022	1.74B	174.74M	11.15%
Dec 31, 2020	1.57B	-73.94M	-4.51%